Veran Medical Technologies is a privately-held medical device company, headquartered in St. Louis, MO. The company has developed and commercialized a unique SPiN Thoracic Navigation System, which includes a hybrid lung cancer diagnostic procedure called SPiNPerc. SPiNPerc combines two main platforms; navigational bronchoscopy and percutaneous navigation, to give physicians more tools in a single procedure to diagnose early stage lung cancer.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/22/15 | $30,600,000 |
3G Capital Advantage Capital Partners Dynamic Investments Prolog Ventures Rex Health Ventures River Cities Capital Funds Vectis Healthcare and Life Sciences Fund Versant Ventures | undisclosed | |
| 12/21/16 | $31,000,000 |
Oxford Finance River Cities Capital Funds Versant Ventures | undisclosed |
